$170,202 (2 years)
Previous research discoveries have indicated that one of the UBE3A target proteins, Arc (activity-regulated cytoskeleton-associated protein) plays a critical role in regulating synaptic plasticity and long-term information storage in the brain. By understanding how Arc is involved in learning and memory in the context of Angelman syndrome (AS) and how it is regulated in the Arc-dependent process, this research has the possibility to lead to development of approaches for therapeutic interventions that target the learning and memory deficits in AS.
The mission of Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.